Amgen acquired Boulder-based Synergen facility
In 1994, Amgen announced it had acquired Boulder-based Synergen for a $239.6-million or $9.25 per share. Synergen was…
Walter Reed Army Medical Center main building was rededicated and named the Heaton Pavilion
In 1994, Walter Reed Army Medical Center main building was rededicated and named the Heaton Pavilion. The Pavillion…
The University of Iowa National Laboratory for the Study of Rural Telemedicine was established
In 1994, the National Laboratory for the Study of Rural Telemedicine was established at the University of Iowa…
The Stowers Institute for Medical Research was founded
In 1994, the Stowers Institute for Medical Research was founded by Jim and Virginia Stowers with a $500…
Infectious molecular clone of a human T-cell leukemia virus was developed at Washington University – St Louis
In 1994, Washington University – St. Louis reseacher Lee Ratern, MD and colleagues announced they had developed an…
National Center for Genome Resources was founded
In 1994, National Center for Genome Resources (NCGR) founded with support from Senator Pete Domenici as an independent…
Diagnostics | Disease | NIH | Oncology | Therapeutics | Women's Health
Albert Einstein College becomes the only New York City medical school selected by the NIH to participate in the Women’s Health Initiative
In 1994, Albert Einstein College of Medicine becomes the only New York City medical school selected by the…
The Medical Research Foundation became an affiliate committee of the OHSU Foundation
In 1994, the Medical Research Foundation (MRF) became an affiliate committee of the Oregon Health & Science University…
The Science Coalition was founded
In 1994, the Science Coalition was founded. The Science Coalition is a nonprofit, nonpartisan organization of more than…
Biotechnology | FDA | Medicine | Therapeutics
FDA approved Risperidone for use as atypical antipsychotic medication
On Dec. 29, 1993, the U.S. Food and Drug Administration (FDA) approved indications for oral risperidone (tablets, oral…
DNA of tuberculosis was isolated from 1,000 Year Old Peruvian mummy
On Dec. 1, 1993, scientists reported the recovery of DNA unique to Mycobacterium tuberculosis from a lung lesion…
Genentech drug Nutropin was approved
On Nov. 17, 1993, Genentech drug Nutropin was approved by the U.S. Food and Drug Administration (FDA) for…
Francisco Mojica characterized CRISPR
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…
Diagnostics | Energy | Genomics | Medical Device | Nanotechnology | Non-Profit Research | Therapeutics
Martin Marietta assumed the Sandia management contract
On Jul. 25, 1993, Sandia Corp. became a Martin Marietta company, leaving the AT&T fold for the first…
Biotechnology | Disease | FDA | Therapeutics
FDA approved Betaseron, the first of several biotech products that have had a major impact on multiple sclerosis treatment
On Jul. 23, 1993, the U.S. Food and Drug Administration (FDA) approved Bayer’s Betaseron, the first of several…
Chiron’s Betaseron was approved as the first treatment for multiple sclerosis in 20 years
On Jul. 23, 1993, Chiron and Berlex Laboratories announced that the U.S. Food and Drug Administration (FDA) had…
Clinical Research | Disease | FDA | IRB | Medicine | Oncology | Therapeutics | Women's Health
FDA issued guidelines calling for improved assessments of medication responses as a function of gender
On Jul. 22, 1993, revising a policy from 1977 that excluded women of childbearing potential from early drug…
ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam Plant building
On May 13, 1993, ZymoGenetics began a $25 million year-long renovation of the The Seattle City Light Steam…
CDC reponded to E. coli Outbreak from Hamburgers in Western United States
On Apr. 16, 1993, the U.S. Centers for Disease Control (CDC) reported that from November 15, 1992, through…
Biotechnology | Chemistry | Disease | FDA | Therapeutics
The Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established
On Apr. 14, 1993, the Earl Davie/ZymoGenetics Endowed Chair of Biochemistry at the University of Washington was established…
Biotechnology | FDA | Oncology | Therapeutics
The FDA approved Amgen’s Epogen/Procrit for the treatment of anemia
On Apr. 1, 1993, the FDA approved Amgen’s Epogen/Procrit for the treatment of anemia due to the effects…
The Pappajohn Clinical Cancer Center opens for service
In 1993, the John and Mary Pappajohn Clinical Cancer Center opened for service after receiving a generous $25…
Oregon Health Policy Institute, an interdisciplinary center of OHSU, Portland State University and Oregon State University was created
In 1993, Oregon Health Policy Institute, an interdisciplinary center of Oregon Health & Science University (OHSU), Portland State…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
The Hollings Cancer Center was founded
In 1993, The Hollings Cancer Center (HCC) was formally was established and named for former U.S. Senator and…
Vanderbilt Cancer Center was established
In 1993, the Vanderbilt Cancer Center was established under the leadership of Dr. Hal Moses, to bring together…
Biotechnology | Diagnostics | NIH | Oncology | Therapeutics
The Cancer Therapy & Research Center at San Antonio received NCI designation
In 1993, The Cancer Therapy & Research Center (CTRC) at San Antonio received National Cancer Institute (NCI) designation….
Jon M and Karen Huntsman donated $10 million to the University of Utah to establish a cancer institute
In 1993, Jon M. and Karen Huntsman donated $10 million to the University of Utah to establish a…
Biotechnology | Clinical Research | Diagnostics | Oncology | Radiology | Therapeutics | Women's Health
The Prostate, Lung, Colorectal, and Ovarian trial began recruiting 148,000 men and women, ages 55-74
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched. The trial was designed to determine whether…
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
Stanford Medicine researchers demonstrated that lifestyle changes and drug therapy decrease heart attack rates
In 1993, Stanford Medicine researchers led by William Haskell demonstrated that lifestyle changes and drug therapy decrease heart…